Latest Articles
How AI is Helping Researchers Find High-Risk Cancers - TheTyee.ca
How AI is Helping Researchers Find High-Risk Cancers TheTyee.ca
Published: July 17, 2024, 7 a.m.
Black patients may be missed on common cancer screening, study suggests - Livescience.com
Black patients may be missed on common cancer screening, study suggests Livescience.com
Published: July 16, 2024, 7 a.m.
Ultrasound Screening Often Misses Endometrial Cancer in Black Females - Healthline
Ultrasound Screening Often Misses Endometrial Cancer in Black Females Healthline
Published: July 9, 2024, 7 a.m.
Mimics of primary ovarian cancer and primary peritoneal carcinomatosis - A pictorial review.
Numerous conditions can mimic ovarian malignancy. Identifying the origin of a pelvic mass or disseminated peritoneal abnormality on imaging is important to ensure that the patient receives optimal management by …
Published: July 9, 2024, midnight
New study finds popular weight-loss and diabetes medications may be linked to lower risk of some cancers - ABC7 Bay Area
New study finds popular weight-loss and diabetes medications may be linked to lower risk of some cancers ABC7 Bay Area
Published: July 8, 2024, 7 a.m.
GLP-1 drugs found to lower cancer risk in diabetes patients - News-Medical.Net
GLP-1 drugs found to lower cancer risk in diabetes patients News-Medical.Net
Published: July 8, 2024, 7 a.m.
The Latest on Targeted Agents, Immunotherapy for Endometrial Cancer - Medpage Today
The Latest on Targeted Agents, Immunotherapy for Endometrial Cancer Medpage Today
Published: July 5, 2024, 7 a.m.
Simon Boas explains how cancer diagnosis helped him enjoy life more - BBC.com
Simon Boas explains how cancer diagnosis helped him enjoy life more BBC.com
Published: July 4, 2024, 7 a.m.
Eleven days after giving birth to premature twins, Tara learned she had cancer - 9Honey
Eleven days after giving birth to premature twins, Tara learned she had cancer 9Honey
Published: July 4, 2024, 7 a.m.
Dostarlimab/Chemo Shows OS Benefit Regardless of MMR Status in Endometrial Cancer - OncLive
Dostarlimab/Chemo Shows OS Benefit Regardless of MMR Status in Endometrial Cancer OncLive
Published: July 3, 2024, 7 a.m.
Link copied to clipboard!